TSR-042: Phase I started

Tesaro began an open-label, U.S. Phase I trial of IV TSR-042 every 2 weeks in

Read the full 159 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE